Azure II (Highly Pure)

<strong>Azure II (Highly Pure)</strong>_x000D_ <strong>Catalog number:</strong> B2018365_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 g_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> RT_x000D_ <strong>Keywords:</strong> Methylene Azure II_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Löhr W, Grubhoffer N, Sohmer I, Wittekind D. The azure dyes: their purification and physicochemical properties. II. Purification of azure B Stain Technol. 1975 May;50(3):149-56._x000D_ 2: Biberoglu K, Yuksel M, Tacal O. Azure B affects amyloid precursor protein metabolism in PS70 cells Chem Biol Interact. 2019 Feb 1;299:88-93._x000D_ 3: Truong L, Ayora F, D'Orsogna L, Martinez P, De Santis D. Nanopore sequencing data analysis using Microsoft Azure cloud computing service PLoS One. 2022 Dec 2;17(12):e0278609._x000D_ 4: Coleman RE, Collinson M, Gregory W, Marshall H, Bell R, Dodwell D, Keane M, Gil M, Barrett-Lee P, Ritchie D, Bowman A, Liversedge V, De Boer RH, Passos-Coelho JL, O'Reilly S, Bertelli G, Joffe J, Brown JE, Wilson C, Tercero JC, Jean-Mairet J, Gomis R, Cameron D. Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04) J Bone Oncol. 2018 Sep 27;13:123-135._x000D_ 5: Wiewiórka M, Szmurło A, Stankiewicz P, Gambin T. Cloud-native distributed genomic pileup operations Bioinformatics. 2023 Jan 1;39(1):btac804._x000D_ 6: de Souza BTL, Klosowski EM, Mito MS, Constantin RP, Mantovanelli GC, Mewes JM, Bizerra PFV, da Silva FSI, Menezes PVMDC, Gilglioni EH, Utsunomiya KS, Marchiosi R, Dos Santos WD, Ferrarese-Filho O, Caetano W, de Souza Pereira PC, Gonçalves RS, Constantin J, Ishii-Iwamoto EL, Constantin RP. The photosensitiser azure A disrupts mitochondrial bioenergetics through intrinsic and photodynamic effects Toxicology. 2021 May 15;455:152766._x000D_ 7: Schneider DK, Soares AS, Lazo EO, Kreitler DF, Qian K, Fuchs MR, Bhogadi DK, Antonelli S, Myers SS, Martins BS, Skinner JM, Aishima J, Bernstein HJ, Langdon T, Lara J, Petkus R, Cowan M, Flaks L, Smith T, Shea-McCarthy G, Idir M, Huang L, Chubar O, Sweet RM, Berman LE, McSweeney S, Jakoncic J. AMX - the highly automated macromolecular crystallography (17-ID-1) beamline at the NSLS-II J Synchrotron Radiat. 2022 Nov 1;29(Pt 6):1480-1494._x000D_ 8: Perea-Sasiaín J. [Giemsa stain's 100th year] Biomedica. 2003 Mar;23(1):5-18._x000D_ 9: Coleman R, Woodward E, Brown J, Cameron D, Bell R, Dodwell D, Keane M, Gil M, Davies C, Burkinshaw R, Houston SJ, Grieve RJ, Barrett-Lee PJ, Thorpe H. Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01-04) for women with stage II/III breast cancer Breast Cancer Res Treat. 2011 Jun;127(2):429-38._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/34026478">10: D'Oronzo S, Gregory W, Nicholson S, Chong YK, Brown J, Coleman R. Natural history of stage II/III breast cancer, bone metastasis and the impact of adjuvant zoledronate on distribution of recurrences J Bone Oncol. 2021 May 4;28:100367. </a>_x000D_ _x000D_ <strong>Products Related to Azure II (Highly Pure) can be found at</strong> <a href="https://moleculardepot.com/product-category/Dyes/"> Dyes</a>